image |
title |
time |
|
Bendamustine We are rapidly transitioning to an innovation and RD-driven pharmaceutical company, leveraging our leading manufacturing
|
2023-01-05 |
|
ApreMilast We are rapidly transitioning to an innovation and RD-driven pharmaceutical company, leveraging our leading manufacturing
|
2023-01-05 |
|
Cabozantinib Malate We are rapidly transitioning to an innovation and RD-driven pharmaceutical company, leveraging our leading manufacturing
|
2023-01-05 |
|
Posaconazole We are rapidly transitioning to an innovation and RD-driven pharmaceutical company, leveraging our leading manufacturing
|
2023-01-05 |
|
Palonosetron HCl We are rapidly transitioning to an innovation and RD-driven pharmaceutical company, leveraging our leading manufacturing
|
2023-01-05 |
|
Edoxaban (tosylate Monohydrate) We are rapidly transitioning to an innovation and RD-driven pharmaceutical company, leveraging our leading manufacturing
|
2023-01-05 |
|
Edaravone We are rapidly transitioning to an innovation and RD-driven pharmaceutical company, leveraging our leading manufacturing
|
2023-01-05 |
|
Lenvatinib Mesylate We are rapidly transitioning to an innovation and RD-driven pharmaceutical company, leveraging our leading manufacturing
|
2023-01-05 |